Cure Alzheimer's Fund Cure Alzheimer's Fund

3DDS: Alzheimer’s Disease Drug Discovery in 3-D

2015, 2016

We propose to examine biological fluids from cells treated with individual drugs that have been approved previously by the U.S. Food and Drug Administration for the treatment of numerous diseases and disorders. We will determine whether these drugs reduce the levels of the toxic proteins known to cause Alzheimer’s disease. Newly identified drugs or similar modified compounds will be developed as Alzheimer’s therapeutics.

Drug Discovery Drug Screening Projects Weiming Xia

Funding to Date

$300,000

Focus

Drug Discovery, Drug Screening Projects

Researchers

Weiming Xia, Ph.D.

Related Content:


Exploring Novel Drug Candidates for Alzheimer’s Disease Through Integrative Pathway Analysis and Validation in 3D Cellular Models Doo Yeon Kim Luisa Quinti 2024-02-01 Development of Small Molecule Inhibitors of Cholesterol 25-hydroxylase Anil Cashikar Bahaa Elgendy 2024-02-01 Validation and Characterization of Compounds Modulating Neuroinflammation and Amyloid Beta Uptake in Microglial Cells Ana Griciuc Luisa Quinti 2023-10-25 Identification and Development of CD33 Inhibitors and Pre-RNA Splicing Modulators Subhash Sinha 2023-10-25 Alzheimer’s Disease Drug Discovery and Development Consortium: Blocking Synaptotoxicity in Alzheimer’s Three-Dimensional Models Weiming Xia 2022-02-17 Alzheimer’s Disease Drug Discovery and Development Consortium: Uncovering the Molecular Mechanism of Selected Drug Candidates Derived from Systematic Alzheimer’s Drug Repositioning Stephen T.C. Wong 2022-02-17 Stimulating Synaptic Proteasome Activity for the Treatment of Alzheimer’s Disease Hermann Steller 2022-02-15 Alzheimer’s Disease Drug Discovery and Development Consortium: High-Throughput Drug Screening for Alzheimer’s Disease Using Three-Dimensional Human Neural Culture Systems Doo Yeon Kim Luisa Quinti 2022-02-14